HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fetal thyrotoxicosis in utero.

Abstract
A case of fetal thyrotoxicosis in utero in a boy with familial predisposition to thyrotoxicosis is reported. At 26 weeks of gestation fetal hyperkinesia and fetal tachycardia developed. This was preceded by a significant pathologic increase in long-acting thyroid stimulator (LATS) in the mother. The fetal hyperkinesia and tachycardia were considered to be signs of fetal thyrotoxicosis, possibly induced by placentally transferred LATS. The fetal thyrotoxicosis responded well to propylthiouracil given to the mother. After birth the boy developed slight signs of neonatal thyrotoxicosis although his serum thyroxine values increased analogous to those of his elder sister, who had presented classical neonatal thyrotoxicosis.
AuthorsJ Serup, S Petersen
JournalBiology of the neonate (Biol Neonate) Vol. 35 Issue 3-4 Pg. 175-9 ( 1979) ISSN: 0006-3126 [Print] Switzerland
PMID435593 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Propylthiouracil
  • Long-Acting Thyroid Stimulator
  • Thyroxine
Topics
  • Female
  • Fetal Diseases (drug therapy, genetics)
  • Humans
  • Hyperkinesis (etiology)
  • Hyperthyroidism (congenital, drug therapy, genetics)
  • Infant, Newborn
  • Long-Acting Thyroid Stimulator (blood)
  • Male
  • Maternal-Fetal Exchange
  • Pregnancy
  • Propylthiouracil (therapeutic use)
  • Tachycardia (etiology)
  • Thyroxine (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: